Clinical Trial Details
— Status: Terminated
Administrative data
| NCT number |
NCT00598494 |
| Other study ID # |
07-007 |
| Secondary ID |
SMS00404 |
| Status |
Terminated |
| Phase |
N/A
|
| First received |
December 26, 2007 |
| Last updated |
January 26, 2017 |
| Start date |
February 2007 |
| Est. completion date |
July 2008 |
Study information
| Verified date |
January 2017 |
| Source |
The Cleveland Clinic |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
The purpose of this research sub-study is to determine the changes in heart function during
the bedrest period using ultrasound and MRI. This topic is important for medical care of
astronauts in space. It can enable physicians on the ground to monitor exercise protocols
that are used to prevent deconditioning-loss of strength during long space flights.
Your participation in this study would include ultrasound examinations with bicycle exercise
before, during, and after the 12-week bedrest period. MRI exams would be performed before
and after the bedrest period.
Each echo exam may last up to 1 hour. This time will be required to perform an ultrasound
examination before and during supine (lying down) bicycle exercise. The exercise period will
be approximately 10-15 minutes. The bicycle exercise will be a symptom-limited test. This
means that the test will be stopped if you experience any discomfort. An ultrasound
examination of your heart will be done to assess heart function. You will be asked to lie on
your left side on an examination table while a technician takes pictures of your heart with
a small probe that is gently pressed against your chest after applying a gel. The ultrasound
data will be processed to evaluate myocardial strain, a value that may be useful in
describing heart function.
Each MRI may last up to 1 hour. An MRI obtains body pictures created by using magnetic
energy rather than x-ray energy. To have the scan, you will lie on a table that slides into
the scanner, which is like a large tube. An MRI examination of your heart will be done to
assess heart function. You will be asked to lie still and follow simple breathing
instructions during the procedure. The MRI data will be processed to evaluate the volume of
blood being pumped by your heart, a value that may be useful in describing heart function.
Description:
NASA and NSBRI are making considerable investment in a bedrest study being conducted at the
Cleveland Clinic Foundation under the directorship of Peter Cavanaugh, primarily to assess
the impact of exercise on prevention of osteoporosis in a twelve-week bedrest study to
simulate microgravity. This provides an outstanding opportunity for synergistic add-on
studies to combine the resources of the bone team of NSBRI with those of the Cardiovascular
Alterations and Smart Medicine by conducting a series of detailed echocardiographic and
computed tomographic examinations of the heart in these patients. These studies will serve
to advance a number of the specific aims of a grant currently held by James D. Thomas from
NSBRI concerning both the primary effects of microgravity on the heart and its reversal with
exercise as well as the ability to prove out new echocardiographic methods for measuring the
cardiac response to exercise. Finally, they will provide an excellent opportunity to prove
out methodologies being developed for remote delivery of healthcare by image fusion from
free-flight studies to in-flight echoes.
We will to pursue the following specific aims with this synergistic study:
Specific Aim 1: To assess the impact of bedrest on cardiac atrophy, stiffening of the left
ventricular diastolic pressure volume curve, and exercise tolerance and ventricular
mechanics and demonstrate at least partial prevention of these changes with the proposed
exercise prescription.
Specific Aim 2: To demonstrate the ability of novel echocardiographic indices of ventricular
function (strain, torsion, IVPG) to predict functional capacity and response to exercise.
Specific Aim 3: To test whether pre-bedrest MRI examinations could be co-registered with
bedrest 3D echocardiographic exams to track atrophy and altered cardiac anatomy. The ability
of detailed 3D ground examinations to be compared precisely with in-flight 3D echos is a key
goal of autonomous medical care system for expedition class missions.
Proposed Protocol (summary):
Pre-bedrest (within 1-3 weeks prior):
1. Resting two and three-dimensional echocardiogram.
2. Maximal supine bicycle test with echocardiographic assessment of wall motion, tissue
strain, tissue torsion, and intraventricular pressure gradients (IVPG) by color M-mode
flow propagation. In addition to the peak exercise assessment, we will also focus on
the submaximal level (heart rate ~100).
3. MRI examination of the heart for LV volume and mass and subsequent cross registration
with echocardiogram.
Six weeks of bedrest:
1. Resting two and three-dimensional echo exam.
2. Low-level supine bicycle exercise echo (HR no greater than 100) with torsion, strain,
and IVPG assessment.
Twelve weeks of bedrest:
1. Resting two and three-dimensional echo.
2. Maximal supine bicycle test with echocardiographic assessment of wall motion, tissue
strain, tissue torsion, and IVPG.
3. MRI examination of the heart.
As part of the overall bedrest protocol (IRB 6504), patients will be randomized either to
complete bedrest with negative tilt vs. those who will undergo daily horizontal treadmill
exercise to replace the calcaneus impact measured pre-bedrest in the same subjects. This
provides an excellent opportunity for assessing the impact of this degree in type of
exercise on the cardiovascular system.
The specific aims of this synergistic study will be answered as follows:
Specific Aim 1: To assess the impact of bedrest on cardiac atrophy, stiffening of the left
ventricular diastolic pressure volume curve, and exercise tolerance and ventricular
mechanics and demonstrate at least partial prevention of these changes with the proposed
exercise prescription.
LV mass will be measured by MRI pre- and post-bedrest and by 3D echo at bedrest stages.
Two-way linear regression will be used to determine change over time in LV mass and to
compare the response to exercise. Similarly, exercise capacity will be analyzed. Among the
LV mechanics parameters that will be available for analysis at all 3 data acquisition points
are: (resting) LV end-diastolic and end-systolic volume, left atrial volume, transmitral E
and A waves and E-wave deceleration time, Doppler tissue annular E, A, and S waves, radial,
circumferential, and longitudinal strain at the midventricular level, LV torsion and peak
untwisting rate, and color M-mode IVPG. These same parameters will also be available for
analysis during low-level (HR 100) bicycle exercise.
Specific Aim 2: To demonstrate the ability of novel echocardiographic indices of ventricular
function at rest (strain, torsion, IVPG) to predict functional capacity and response to
exercise.
Strain, torsion, and IVPG will be assessed at all stages and correlated with changes in
cardiac atrophy parameters (LV mass and volumes).
Specific Aim 3: To test whether pre/post bedrest MRI examinations can be co-registered with
bedrest 3D echocardiographic exams to track atrophy and altered cardiac anatomy. The ability
of detailed 3D ground examinations to be compared precisely with in-flight 3D echos is a key
goal of autonomous medical care system for expedition class missions.
